OPHIDIAN PHARMACEUTICALS, INC.
OPHIDIAN PHARMACEUTICALS PROPOSES TO TEST THE FEASIBILITY OF ADAPTING ITS TECHNOLOGY FOR PRODUCING AND PURIFYING THERAPEUTIC ANTIBODIES FROM THE EGG YOLKS OF HYPERIMMUNIZED LAYING HENS TO THE DEVELOPM ...SBIR Phase II 1992 ArmyDepartment of Defense
Helicobacter pylori is a gastrointestinal pathogen that causes, or is a major risk factor for thedevelopment of a spectrum of diseases including chronic gastritis, peptic ulcer, and cancer of thestoma ...SBIR Phase I 1994 Department of Health and Human Services
E. coli Ol57:H7 is an emerging food-borne pathogen with substantial morbidity and mortality.There are an estimated 20,000 cases of E. coli 0157:H7 infection per year in the United States.However, only ...SBIR Phase II 1996 Department of Health and Human Services
The northward migration from Brazil of the Africanized honey bee (AHB), Apis mellifera scutellata, following their accidental release presents a new U. S. public health concern. Because of the AHB's e ...SBIR Phase I 1993 Department of Health and Human Services
A novel set of compounds has been devised and synthesized, members of which bind to bacterial toxins with high affinity and selectivity. The compounds are covalently attached to a solid phase and can ...SBIR Phase I 1998 ArmyDepartment of Defense
N/ASBIR Phase I 1991 ArmyDepartment of Defense
N/ASBIR Phase I 1994 Department of Health and Human Services